Direct HGH: Bypassing the Feedback System
Synthetic human growth hormone (somatropin) delivers a fixed pharmacological dose that overrides the body’s natural GH regulation. The pituitary’s somatostatin feedback system — which normally moderates GH levels — is bypassed. This is effective but carries risks associated with supraphysiological GH levels, including fluid retention, carpal tunnel symptoms, joint discomfort, and concerns about long-term effects with prolonged use.
Secretagogues: Working With the System
Peptides like Sermorelin, CJC-1295, and Ipamorelin stimulate the pituitary to produce GH in a more physiological pattern. The body’s own feedback systems remain active — somatostatin can still moderate GH release. This self-regulation means the body maintains more control over total GH output, which is why many physicians consider secretagogues a more conservative approach for most patients.
Cost Comparison
Pharmaceutical HGH (somatropin) is significantly more expensive than compounded GH secretagogue peptides — often $1,000-$2,000+ per month versus $150-$400 for peptide protocols. Cost alone makes secretagogues the practical choice for most patients without documented severe GH deficiency.
Who Needs Direct HGH
Direct HGH replacement is typically reserved for patients with documented severe growth hormone deficiency confirmed by provocative testing. For the broader population interested in GH optimization, secretagogue peptides are typically the more appropriate starting point.